Up-to-date report of botulinum toxin type A treatment in patients with gustatory sweating (Frey's Syndrome)

Laryngoscope

Volumn 108, Issue 3, 1998, Pages 381-384

  Laskawi, Rainer ^a,b   Drobik, Christian ^a   Schönebeck, Claudia ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FREY SYNDROME; HUMAN; INTRADERMAL DRUG ADMINISTRATION; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SWEAT GLAND DISEASE; SWEATING; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BOTULINUM TOXIN TYPE A; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRADERMAL; MALE; MIDDLE AGED; PAROTID GLAND; PATIENT SATISFACTION; POSTOPERATIVE COMPLICATIONS; RECURRENCE; SWEATING, GUSTATORY;

EID: 0031906710     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-199803000-00013     Document Type: Article

References (19)

1. Frey L. Le syndrome du nerf auriculotemporal. Rev Neur (Fr) 1923;30:97-104.
2. Miehlke A. Sequelae of facial palsy and parotidectomy. In: Miehlke A, ed. Surgery of the Facial Nerve. München: Urban und Schwarzenberg; 1973:222-5.
3. Laage-Hellmann JE. Gustatory sweating and flushing after conservative parotidectomy. Acta Otolaryngol (Stockh) 1957;48:235-52.
4. Laage-Hellman JE. Gustatory sweating and flushing: aetiological implications of response of separate sweat glands to various stimuli. Acta Otolaryngol (Stockh) 1958;49:363-74.
5. May JS, McGuirt WF. Frey's syndrome: treatment with topical glycopyrrolate. Head Neck Surg 1989;11:85-9.
6. Laskawi R, Schott T, Mirzaie-Petri M, Schröder M. Surgical management of pleomorphic adenomas of the parotid gland: a follow-up study of three methods. J Oral Maxillofac Surg 1996;54:1176-9.
7. Drobik C, Laskawi R. Frey-Syndrom: Behandlung mit Botulinum Toxin. HNO Aktuell 1994;2:142-4.
8. Drobik C, Laskawi R. Frey's syndrome: treatment with botulinum toxin. Acta Otolaryngol (Stockh) 1995;115:459-61.
9. Drobik C, Laskawi R, Schwab S. Die Therapie des Frey-Syndroms mit Botulinumtoxin A. HNO 1995;43:644-648
10. Hambleton P, Moore AP. Botulinum neurotoxins: origins, structure, molecular actions and antibodies. In Moore P, ed. Handbook of Botulinum Toxin Treatment. Oxford: Blackwell Science; 1995:16-27.
11. Moore AP. General and clinical aspects of treatment with botulinum toxin. In Moore P, ed. Handbook of Botulinum Toxin Treatment. Oxford: Blackwell Science; 1995:16-27.
12. Schulze-Bonhage A, Schröder M, Ferbert A. Botulinum toxin in the therapy of gustatory sweating. J Neurol 1996;243:143-6.
13. Minor V. Ein neues Verfahren zu der klinischen Untersuchung der Schweißabsonderung. Dtsch Z Nervenheilk 1927;101:302-6.
14. Laskawi R, Drobik C. Botulinumtoxintherapie beim idiopathischen Torticollis spasmodicus. Otorhinolaryngol Nova 1993;3:257-62.
15. Laskawi R, Damenz W, Roggenkämper P, Baetz A. Botulinum toxin treatment in patients with facial synkinesis. Eur Arch Otorhinolaryngol Suppl 1994:195-9.
16. Laskawi R, Ellies M, Drobik C, Bätz A. Botulinum toxin treatment in patients with hemifacial spasm. Eur Arch Otorhinolaryngol 1994;251:271-4.
17. Laskawi R. Combination of hypoglossal-facial nerve anastomosis and botulinum toxin injections to optimize mimic rehabilitation following removal of acoustic neurinomas. Plast Reconstr Surg 1997;99:1006-11.
18. Stell R, Moore AP. History and current applications of botulinum toxin treatment. In: Moore P, ed. Handbook of Botulinum Toxin Treatment. Oxford: Blackwell Science; 1995:16-27.
19. Schliack H. Zum Problem der Schweißdrüseninnervation. Der Nervenarzt 1962;9:421-3.